Arthritis Treatment - Business Week - Another Ailing Miracle Drug March 14, 2005
Business Week - Another Ailing Miracle Drug
March 14, 2005 — When the immune system goes bad, it goes very, very bad. Some 80 known diseases are caused by out-of-control immune cells that attack the body’s own organs — among them multiple sclerosis, rheumato
Chain Drug Review - Kineret Given Okay By FDA Advisory Panel.(Amgen Inc. rheumatoid arthritis treatment)(Brief Article)
September 24, 2001 — THOUSAND OAKS, Calif. — The arthritis advisory panel of the Food and Drug Administration has recommended the agency approve Kineret, a biologic therapy developed by Amgen Inc. for the treatment
Drug Store News - Whitehall-Robins - advertises Advil as arthritis treatment during National Arthritis Month - Brief Article
April 23, 2001 — MADISON, N.J. — In preparation for National Arthritis Month in May, Whitehall-Robins earlier this quarter, introduced a new “arthritis-friendly” cap …
Drug Store News - SAB-Pharma - Supplier News - SAB-Pharma offers gold sodium thiomalate as rheumatoid arthritis treatment in the United States - Brief Article
November 3, 2003 — SAB-Pharma announced that its gold sodium thiomalate is available for treating select cases of active rheumatoid arthritis in adults and children. The …
Townsend Letter for Doctors and Patients - Rheumatoid arthritis and laughter
December 1, 2005 — In 26 rheumatoid arthritis women patients age 43-66, mean duration of disease 19.4 years, and 31 healthy female controls, exposure to Rakugo (traditional …
Medical Marketing & Media - FDA reviews European warning on Arava.(Food and Drug Administration, Aventis’ rheumatoid arthritis treatment)(Brief Article)
May 1, 2001 — The FDA is reviewing data developed by the European Medicines Evaluation Agency (EMEA) on reports of serious liver injuries in patients with rheumatoid …
Applied Clinical Trials - Amgen Inc.(Kineret approved for rheumatoid arthritis treatment)
January 1, 2002 — FDA has approved Kineret (anakinra; Amgen Inc., Thousand Oaks, CA)) for reducing signs and symptoms of moderately to severely active rheumatoid arthritis …

